Regentis Biomaterials Ltd. (RGNT)

Last Closing Price: 2.15 (2026-05-21)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Regentis Biomaterials Ltd. (RGNT) Stock-Based Compensation data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$7.62M
--
--
$7.62M
$2.87M
--
--
$2.87M
$4.74M
$4.74M
$4.74M
--
Cash Flow Statement Financials
$-1.38M
$0.00M
$8.52M
$0.23M
$7.38M
$7.15M
Stock-Based Compensation
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--